Navigation Links
GENova gains access to Big Pharma
Date:9/15/2009

NEW YORK, NY, Sept. 15 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) - GENova Biotherapeutics Inc. ("GENova"), a cancer drug acquisition and development company, is pleased to announce it has gained access to distribution channels for its promising drug targets through a recently-signed deal with Bridge BioResearch Plc. ("Bridge BioResearch"). GENova expects to generate licensing fees and royalties from the out-licensed manufacturing and marketing rights to leading pharmaceutical companies to exceed more than 5% in a market currently valued at $3billion+ a year over the following 15-20 years which is the duration of the patents.

Bridge BioResearch is an international drug discovery company that focuses on metabolic disorders, and has well-established distribution channels and relationships with leading pharmaceutical companies.

Through a recent collaboration deal, the two companies are working together to leverage their respective Research and Development partners and distribution channels worldwide, with the mutual goal of developing their proprietary drug targets with the utmost cost and time efficiency.

The two companies are both in the business of acquiring early-stage developmental drugs, out-licensing them for development and commercialization, and garnering royalty payments in the process. GENova's focus is oncology, while Bridge BioResearch specializes in Obesity and Type 2 Diabetes drugs. Both companies share a mutual goal of fast-tracking their target drugs through development, clinical studies, licensing to Big Pharma such as Biogen, Elan, Merck's and Genentech.

"This reciprocal arrangement is a huge benefit to both companies," says Aaron Whiteman, CEO for GENova. "I am confident that with our new access to Big Pharma distribution channels we can usher our promising patents through the development process as expeditiously as possible, and ultimately start reaping royalty payments sooner than ever foreseen."


'/>"/>
SOURCE GENova Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. GENova names Aaron Whiteman as CEO
2. GENova names Dr. John Savin as Vice President
3. Genova files patent for new prostate cancer treatment
4. GENova appoints Dr. Anders Boegh Jensen to Scientific Advisory Board
5. GENova discusses development of new anti-cancer biotechs potentially worth $400 Million per annum
6. GENova appoints Director of Asian business development
7. GENova files patent for new breast cancer treatment
8. GENova to acquire three new drug target patents worth in excess of $1 billion in royalty fees
9. GENova issues clarifying press release
10. GENova appoints Dr. Philip Gould to Scientific Advisory Board
11. GENova appoints Dr. Wang Chong to Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2014)... In the recent years, there has been a ... an increase in the number of web hosting companies ... very affordable prices. , The famous SEO hosting review ... suppliers and announced that Bluehost ( http://www.bluehost.com/track/seohosts ), Arvixe ... 2014. Those who want to obtain high quality WordPress ...
(Date:9/13/2014)... (PRWEB) September 14, 2014 Recently, an ... gowns, iFitDress.com, has announced its new collection of ... them are offered at discounted rates, up to 58% ... will be valid until September 23. , The ... in the market, including vintage, plus size, modest, sexy ...
(Date:9/13/2014)... New York, NY (PRWEB) September 13, 2014 ... developers and medical device manufacturers turn to operators ... improve operating efficiencies and manage risk. “Over the ... increased due to technological advances in the healthcare ... IBISWorld Industry Analyst Jocelyn Phillips. Moreover, the 2010 ...
(Date:9/13/2014)... HealthDay Reporter SATURDAY, Sept. 13, 2014 (HealthDay ... being treated at a Nebraska medical center is getting his ... been a patient in the hospital,s isolation unit since being ... On Friday, the hospital said that Sacra satisfied a ... Jerry,s Chocolate Chip Cookie Dough, the Associated Press ...
(Date:9/13/2014)... 2014 Gainesville Fit Body Boot ... their official Grand Opening celebration today, Saturday, September 13th, ... international Fit Body Boot Camp franchise, which is known ... get busy people the fast results they’re looking for ... are hard work, but we make them fun as ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Considers Bluehost, GoDaddy and Arvixe as the Best SEO Hosting Suppliers 2Health News:Cheap Eggplant Evening Dresses Now Announced By Experienced Company iFitDress.com 2Health News:Healthcare Consultants in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Healthcare Consultants in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:American Ebola Patient Gets Appetite Back 2Health News:American Ebola Patient Gets Appetite Back 3Health News:Gainesville Fit Body Boot Camp Announces Grand Opening of New Fitness Boot Camp 2Health News:Gainesville Fit Body Boot Camp Announces Grand Opening of New Fitness Boot Camp 3
... Reporter , THURSDAY, June 23 (HealthDay News) -- After suffering ... hopes and fears about the future are less depressed and ... In fact, 48 percent of the people who participated ... stroke were not depressed a year later, compared to 37.7 ...
... stress appears to enhance the lung-damaging effects of traffic-related ... the Keck School of Medicine of the University of ... will appear online ahead of the print edition of ... and Critical Care Medicine . "This is the ...
... team led by Johns Hopkins researchers has found that a ... with abnormally dense blood vessel growth in the skin lining ... of Familial Cancer , could lead to a quick ... DNA tests and colonoscopies, and sometimes goes unnoticed until cancer ...
... News) -- Among heart attack patients, black Americans generally ... restore blood flow to their hearts, according to a ... hospital quality, not the race of individual patients, the ... attack patients who arrive at hospitals that aren,t equipped ...
... media use, encouraging infants and young children in preschool ... active play, and requiring child care providers to promote ... to curb high rates of obesity among America,s youngest ... Medicine. The report recommends steps that ...
... the Georgia Tech Research Institute (GTRI) have developed a ... disease and certain other neurological conditions to use the ... tremors and relay the results to medical personnel. ... replace subjective tests now used to assess the severity ...
Cached Medicine News:Health News:Early Talk Therapy May Help Stroke Patients Bounce Back 2Health News:Early Talk Therapy May Help Stroke Patients Bounce Back 3Health News:Exposure to parental stress increases pollution-related lung damage in children 2Health News:Hereditary colon cancer syndrome marked by abnormally dense blood vessel growth in mouth 2Health News:Hereditary colon cancer syndrome marked by abnormally dense blood vessel growth in mouth 3Health News:Hospital Delays Tied to Racial Divide in Heart Attack Care 2Health News:Policies that promote healthy eating, activity and sleep are needed to curb obesity in infants, toddlers and preschoolers 2Health News:Policies that promote healthy eating, activity and sleep are needed to curb obesity in infants, toddlers and preschoolers 3Health News:Policies that promote healthy eating, activity and sleep are needed to curb obesity in infants, toddlers and preschoolers 4Health News:New application for iPhone may support monitoring and research on Parkinson's disease 2Health News:New application for iPhone may support monitoring and research on Parkinson's disease 3
(Date:9/14/2014)... , Sept. 14, 2014  Amgen (NASDAQ: AMGN ) ... ystolic H eart failure treatment with the ... T rial) study evaluating ivabradine in patients with chronic ... Annual Scientific Meeting of the Heart Failure Society of America ... analysis from the SHIFT study confirmed low systolic blood pressure ...
(Date:9/14/2014)... Sept. 14, 2014  Abbott announced today positive ... first prospective, randomized, controlled trial comparing the safety ... to Abbott,s market-leading metallic XIENCE family of DES.  ... , included 501 people with coronary artery ... disease. The results were featured at a late-breaking ...
(Date:9/13/2014)... , Sept. 13, 2014  Edwards Lifesciences ... leader in the science of heart valves and ... clinical outcomes for inoperable patients treated in The ... for transcatheter aortic valve replacement (TAVR) in patients ... were presented as part of the late-breaking clinical ...
Breaking Medicine Technology:Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 2Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 3Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 4Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 5Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 6Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 7Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 8Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 9ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 2ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 3ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 4ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 5Significant Patient Benefits With Edwards Sapien Valve Demonstrated In 5-Year Partner Trial Data 2
... Sanmina-SCI Corporation (Nasdaq: SANM ), a ... world,s most complex and valuable electronic and mechanical ... has been awarded ISO 13485 certification for medical ... manufacturing capabilities, and the company,s focus on meeting ...
... Sept. 8, 2011 Marshall Edwards, Inc. (Nasdaq: ... clinical development of novel therapeutics targeting cancer metabolism, announced ... of the Company,s lead drug candidate ME-143 in patients ... in collaboration with the Sarah Cannon Research Institute in ...
Cached Medicine Technology:Sanmina-SCI Kenosha, Wisconsin Facility Awarded ISO 13485 Certification for Medical Devices 2Sanmina-SCI Kenosha, Wisconsin Facility Awarded ISO 13485 Certification for Medical Devices 3Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143 2Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143 3
Flattened 13 mm "Graefe type" hook, with 1.5 mm oval hole. Flat serrated handle with polished finish. Overall length: 5.6 inches....
Fine short working end. Overall length: 4.9 inches. Most popular size or model....
Designed for manipulating one piece lenses. The "Y: hook is excellent for capturing haptics and centering the lens. Straight shaft with "Y" shaped tip. Round knurled handle with dull finish. Overall ...
0.3 mm hook angled 45 degrees, 9 mm from tip to bend. Flat smooth handle with polished finish. Overall length: 4.6 inches....
Medicine Products: